Fecal microbiota transplantation and donor standardization

Trends in Microbiology

Volumn 21, Issue 9, 2013, Pages 443-445

  Owens, Casey ^a   Broussard, Elizabeth ^a   Surawicz, Christina ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Clostridium difficile; Diarrhea; Fecal microbiota transplant

Indexed keywords

BIOLOGICAL THERAPY; CLINICAL EFFECTIVENESS; CLOSTRIDIUM DIFFICILE INFECTION; DONOR SELECTION; FECAL MICROBIOTA TRANSPLANTATION; HUMAN; INTESTINE FLORA; NOTE; PATIENT ASSESSMENT; PATIENT COUNSELING; PATIENT SELECTION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SCREENING TEST; STANDARDIZATION; TRANSPLANTATION;

CLOSTRIDIUM DIFFICILE; DIARRHEA; FECAL MICROBIOTA TRANSPLANT;

BIOLOGICAL THERAPY; CLOSTRIDIUM DIFFICILE; DIARRHEA; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FECES; HUMANS; MICROBIOTA;

EID: 84883782129     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2013.07.003     Document Type: Note

References (14)

1. Musher D.M., et al. Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. Clin. Infect. Dis. 2005, 40:1586-1590.
2. Brandt L., et al. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridum difficile infection. Am. J. Gastroenterol. 2012, 107:1079-1087.
3. Surawicz C., et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am. J. Gastroenterol. 2013, 108:478-498.
4. van Nood E., et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N. Engl. J. Med. 2013, 638:407-415.
5. Mattila E., et al. Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection. Gastroenterology 2012, 142:490-496.
6. Louie T., et al. Fidaxomicin versus vancomycin for Clostridium difficile infection. N. Engl. J. Med. 2011, 364:422-431.
7. Bakken J., et al. Treating Clostridium difficile infection with fecal microbiota transplantation. Clin. Gastroenterol. Hepatol. 2011, 9:1044-1049.
8. Gough E., et al. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin. Infect. Dis. 2011, 53:994-1002.
9. Tvede M., Rask-Madsen J. Bacteriotherapy for chronic relapsing Clostridium difficile diarrhea in six patients. Lancet 1989, 1:1156-1160.
10. Khoruts A., et al. Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J. Clin. Gastroenterol. 2010, 44:354-360.
11. Johnston B., et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis. Ann. Intern. Med. 2012, 157:878-888.
12. Lowy I., et al. Treatment with monoclonal antibodies against Clostridium difficile toxins. N. Engl. J. Med. 2010, 362:197-205.
13. Sougioultzis S., et al. Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea. Gastroenterology 2005, 128:764-770.
14. Seregin S., et al. Adenovirus-based vaccination against Clostridium difficile toxin A allows for rapid humoral immunity and complete protection from toxin A lethal challenge in mice. Vaccine 2012, 30:1492-1501.